Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 59

Sort by

Sort Order Select

Journal Articles

Late Effects and Subsequent Neoplasms in Survivors of Adolescent and Young Adult Acute Lymphoblastic Leukemia: A Population-Based Analysis Including Impact of Front-Line Regimen Type

Lori S Muffly, MD, Fran Maguire, PhD MPH, Qian Li, MS, Vanessa Kennedy, MD, Theresa H.M. Keegan, PhD MS

Blood (2019) 134 (Supplement_1): 421.

https://doi.org/10.1182/blood-2019-124992

Published: 2019

Journal Articles

Implementation of a Cardio Oncology Protocol in Uruguay

Pía Oldan, MD, Andreina Gomez, MD, Gabriel Parma, MD, Cecilia Guillermo, MD, Lilián Díaz, MD, Matilde Boada, MD MSc

Blood (2019) 134 (Supplement_1): 5888.

https://doi.org/10.1182/blood-2019-127068

Published: 2019

Journal Articles

Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double Blinded Phase IIb Trial

Blood (2019) 134 (Supplement_1): 2843.

https://doi.org/10.1182/blood-2019-126661

Published: 2019

Journal Articles

Medical Conditions Among Survivors of Adolescent and Young Adult Non-Hodgkin Lymphoma (NHL), Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)

Theresa H.M. Keegan, PhD MS, Lori S Muffly, MD, Qian Li, MS, Elysia Alvarez, MD MPH, Ann M Brunson, MS, Marcio Malogolowkin, MD, Ted Wun, MD

Blood (2018) 132 (Supplement 1): 839.

https://doi.org/10.1182/blood-2018-99-111553

Published: 2018

Journal Articles

Survival Outcomes of Patients with Therapy-Related Myelodysplastic Syndromes in the United States

Raffi Tchekmedyian, BS, Tomas Radivoyevitch, PhD, Aaron T. Gerds, MDMS, Aziz Nazha, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Jaroslaw P. Maciejewski, Matt Kalaycio, MD, Navneet S. Majhail, MD MS, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MDPhDMPH

Blood (2018) 132 (Supplement 1): 371.

https://doi.org/10.1182/blood-2018-99-119661

Published: 2018

Journal Articles

Recipients of Myelotoxic Chemotherapy Have Increased Prevalence of Clonal Hematopoiesis of Indeterminate Potential (CHIP) with a Typical Distribution of Chip-Associated Mutations

Adam J Olszewski, MD, Anna Dorota Chorzalska, PhD, Annette S. Kim, MD PhD, Peter J. Quesenberry, MD, Mary L Lopresti, DO, Mary Anne Fenton, MD, John L. Reagan, MD, James Butera, MD, Ilyas Sahin, MD, Celine Hamel, CRA, Jordan Robison, CRA, Max Petersen, Patrycja Dubielecka, PhD

Blood (2018) 132 (Supplement 1): 3841.

https://doi.org/10.1182/blood-2018-99-111436

Published: 2018

Journal Articles

Rituximab (R)-CHOP Therapy Has Progressed Arteriosclerosis with an Elevation of Von Willebrand Factor (vWF) in Patients with Malignant Lymphoma

Naomi Shimizu, MD, Shouko Nakamura, MD, Naoyuki Kawagoe, MD PhD, Rena Oka, MD PhD, Yasuhiro Watanabe, MD PhD, Sho Tanaka, MD, Yuta Sato, MD PhD, Takashi Yamaguchi, MD PhD, Masahiro Ohira, MD PhD, Atsuhito Saiki, MD PhD, Chiaki Nakaseko, MD PhD, Emiko Sakaida, MD PhD, Hideaki Bujo, MD PhD, Kohji Shirai, MD PhD, Ichiro Tatsuno, MD PhD

Blood (2018) 132 (Supplement 1): 5380.

https://doi.org/10.1182/blood-2018-99-112326

Published: 2018

Journal Articles

Patient-Reported and Neurocognitive Outcomes in Patients Treated with Axicabtagene Ciloleucel

Heather S.L. Jim, PhD, Aasha I. Hoogland, PhD, Aaron Collier, Margaret Booth-Jones, PhD, Michael D. Jain, MD PhD, Frederick L. Locke, MD

Blood (2018) 132 (Supplement 1): 2289.

https://doi.org/10.1182/blood-2018-99-111711

Published: 2018

Journal Articles

Impact of Prior Cancer on Eligibility for Plasma Cell Disorder (PCD) Clinical Trials

Sandra Garcia, Olivia Dorsey, MSIS, Sandi Pruitt, PhD MPH, Saurabh Dahiya, MD, David Gerber, MD, Robert Frank Cornell, MD, Daniel Auclair, PhD, Robert H. Collins, MD, Steven Devine, Saad Z. Usmani, MD, Larry Anderson, MD PhD, Shaji K. Kumar, MD, Ankit Kansagra, MD

Blood (2018) 132 (Supplement 1): 2267.

https://doi.org/10.1182/blood-2018-99-113510

Published: 2018

Journal Articles

Cognitive Outcomes Among Patients with Hematological Cancer with Access to Computerized Cognitive Training: Results from a Feasibility Study

Samantha J Mayo, RN PhD, Eshetu G Atenafu, MSc, P.Stat, Sean B Rourke, PhD, John Kuruvilla, MD, Christine I Chen, MD FRCP(C)

Blood (2017) 130 (Supplement 1): 3454.

https://doi.org/10.1182/blood.V130.Suppl_1.3454.3454

Published: 2017

Journal Articles

Risk of Subsequent Malignant Neoplasms in Survivors of Adolescent and Young Adult (AYA) Lymphoma and Leukemia

Chun Chao, PhD, Lanfang Xu, Kim Cannavale, F Lennie Wong, Po-Yin Huang, Robert Cooper, Smita Bhatia, MDMPH, Saro H. Armenian, DO,MPH

Blood (2017) 130 (Supplement 1): 608.

https://doi.org/10.1182/blood.V130.Suppl_1.608.608

Published: 2017

Journal Articles

Survival Among Acute Lymphocytic Leukemia Patients Conditional on Years Already Survived and Relative to the General Population in the United States

Raffi Tchekmedyian, BS, Aziz Nazha, MD, Anjali S. Advani, MD, Aaron T. Gerds, MDMS, Hetty E. Carraway, MD MBA, Matt Kalaycio, MD, Jaroslaw P. Maciejewski, PhD MD FACP, Navneet S. Majhail, MD MS, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MD PhD MPH

Blood (2017) 130 (Supplement 1): 347.

https://doi.org/10.1182/blood.V130.Suppl_1.347.347

Published: 2017

Journal Articles

Increased Incidence of Autoimmune and Infectious Diseases Among a Large Group of Diffuse Large B-Cell Lymphoma (DLBCL) Survivors: A Population-Based Study

Tanaya Shree, MD PhD, Qian Li, MS, Sally L. Glaser, PhD, Holden T. Maecker, PhD, Robert W. Haile, PhD MPH, Ronald Levy, MD, Theresa H.M. Keegan, PhD MS

Blood (2017) 130 (Supplement 1): 198.

https://doi.org/10.1182/blood.V130.Suppl_1.198.198

Published: 2017

Journal Articles

Favorable Impact of Allogeneic Stem Cell Transplantation in Patients with Therapy-Related Myelodysplasia Regardless of TP53 Mutational Status

Blood (2017) 130 (Supplement 1): 4248.

https://doi.org/10.1182/blood.V130.Suppl_1.4248.4248

Published: 2017

Journal Articles

Phlebotomy for Pediatric and Young Adult Oncology Patients Treats Transfusional Iron Overload

Nathan Schloemer, MD, Melissa Acquazzino, MD, Rachel Phelan, MDMPH, Debra Schmidt, APNP, Lynnette Anderson, APNP, Sandra Steffes, RN, BSN, Richard L. Tower, MD MS, J. Paul Scott, MD

Blood (2017) 130 (Supplement 1): 941.

https://doi.org/10.1182/blood.V130.Suppl_1.941.941

Published: 2017

Journal Articles

The Level of Physical Activity before and after Lymphoma Diagnosis Impacts Overall and Lymphoma-Specific Survival

Priyanka Pophali, MD, Melissa C. Larson, M.S., Allison C. Rosenthal, DO, Matthew J Maurer, MS, Jonathon B Cohen, MDMS, Andrew Ip, MD, Christopher Flowers, MD, Brian K Link, MD, Umar Farooq, MD, Andrew L Feldman, MD, Cristine Allmer, BS, Susan L Slager, PhD, Thomas M Habermann, MD, James R. Cerhan, MD PhD, Carrie A Thompson, MD

Blood (2017) 130 (Supplement 1): 914.

https://doi.org/10.1182/blood.V130.Suppl_1.914.914

Published: 2017

Journal Articles

Social Support Source and Effectiveness Are Associated with Distress Among Hematopoietic Stem Cell Transplant Survivors Experiencing Stress Due to Negative Life Events after Treatment

Christine Rini, PhD, Marjorie Margolis, MSPH, Jane Austin, PhD, Heiddis Valdimarsdottir, PhD, Lisa Wu, PhD, Annette Stanton, PhD, Scott D. Rowley, MD

Blood (2017) 130 (Supplement 1): 2164.

https://doi.org/10.1182/blood.V130.Suppl_1.2164.2164

Published: 2017

Journal Articles

Prognostic Impact of Past History of Other Malignancies in Diffuse Large B Cell Lymphoma

Kazuna Tanba, MD, Yoshiaki Chinen, MDPhD, Hitoji Uchiyama, MD PhD, Nobuhiko Uoshima, MD PhD, Kazuho Shimura, MD PhD, Shin-ichi Fuchida, MD PhD, Miki Kiyota, MD PhD, Mitsushige Nakao, MD PhD, Yuji Shimura, MD PhD, Tsutomu Kobayashi, MD PhD, Shigeo Horiike, MD PhD, Katsuya Wada, MD PhD, Chihiro Shimazaki, MD PhD, Hiroto Kaneko, MD PhD, Yutaka Kobayashi, MD PhD, Masafumi Taniwaki, MD PhD, Junya Kuroda, MD PhD

Blood (2017) 130 (Supplement 1): 1570.

https://doi.org/10.1182/blood.V130.Suppl_1.1570.1570

Published: 2017

Journal Articles

Elevation of Cardio-Ankle Vascular Index in Patients with Malignant Lymphoma Treated with R-CHOP Regimen

Naomi Shimizu, MD PhD, Yasuhiro Watanabe, MD, Shouko Nakamura, MD, Sho Tanaka, MD, Rena Oka, MD, Yuta Sato, MD PhD, Haruki Imamura, MD PhD, Takashi Yamaguchi, MD PhD, Chiaki Nakaseko, MDPhD, Emiko Sakaida, MD PhD, Hideaki Bujo, MD PhD, Kohji Shirai, MD PhD, Ichiro Tatsuno, MD PhD

Blood (2017) 130 (Supplement 1): 5151.

https://doi.org/10.1182/blood.V130.Suppl_1.5151.5151

Published: 2017

Journal Articles

The Impact of Prior Malignancies on Second Malignancies and Survival in MM Patients: A Population-Based Study

Gudbjorg Jonsdottir, MD, Sigrún H. Lund, PhD, Magnus Björkholm, MD, PhD, Ingemar Turesson, MD, PhD, Anders Wahlin, MD, Prof., Malin Hultcrantz, MD, PhD, Anna Porwit, MD, PhD, Ola Landgren, MD, PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 3246.

https://doi.org/10.1182/blood.V128.22.3246.3246

Published: 2016

NARROW

Late Effects and Subsequent Neoplasms in Survivors of Adolescent and Young Adult Acute Lymphoblastic Leukemia: A Population-Based Analysis Including Impact of Front-Line Regimen Type

Implementation of a Cardio Oncology Protocol in Uruguay

Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double Blinded Phase IIb Trial

Medical Conditions Among Survivors of Adolescent and Young Adult Non-Hodgkin Lymphoma (NHL), Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)

Survival Outcomes of Patients with Therapy-Related Myelodysplastic Syndromes in the United States

Recipients of Myelotoxic Chemotherapy Have Increased Prevalence of Clonal Hematopoiesis of Indeterminate Potential (CHIP) with a Typical Distribution of Chip-Associated Mutations

Rituximab (R)-CHOP Therapy Has Progressed Arteriosclerosis with an Elevation of Von Willebrand Factor (vWF) in Patients with Malignant Lymphoma

Patient-Reported and Neurocognitive Outcomes in Patients Treated with Axicabtagene Ciloleucel

Impact of Prior Cancer on Eligibility for Plasma Cell Disorder (PCD) Clinical Trials

Cognitive Outcomes Among Patients with Hematological Cancer with Access to Computerized Cognitive Training: Results from a Feasibility Study

Risk of Subsequent Malignant Neoplasms in Survivors of Adolescent and Young Adult (AYA) Lymphoma and Leukemia

Survival Among Acute Lymphocytic Leukemia Patients Conditional on Years Already Survived and Relative to the General Population in the United States

Increased Incidence of Autoimmune and Infectious Diseases Among a Large Group of Diffuse Large B-Cell Lymphoma (DLBCL) Survivors: A Population-Based Study

Favorable Impact of Allogeneic Stem Cell Transplantation in Patients with Therapy-Related Myelodysplasia Regardless of TP53 Mutational Status

Phlebotomy for Pediatric and Young Adult Oncology Patients Treats Transfusional Iron Overload

The Level of Physical Activity before and after Lymphoma Diagnosis Impacts Overall and Lymphoma-Specific Survival

Social Support Source and Effectiveness Are Associated with Distress Among Hematopoietic Stem Cell Transplant Survivors Experiencing Stress Due to Negative Life Events after Treatment

Prognostic Impact of Past History of Other Malignancies in Diffuse Large B Cell Lymphoma

Elevation of Cardio-Ankle Vascular Index in Patients with Malignant Lymphoma Treated with R-CHOP Regimen

The Impact of Prior Malignancies on Second Malignancies and Survival in MM Patients: A Population-Based Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only